Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, Lionel, Ghiringhelli, François, Tesniere, Antoine, Obeid, Michel, Ortiz, Carla, Criollo, Alfredo, Mignot, Grégoire, Maiuri, M Chiara +20 more·2007·Nature Medicine

Cited by (1,010)

Items 901–1,000 of 1,010

  1. Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
    Maria Davern, Joanne Lysaght · 2020 · Cancer Letters
  2. Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review
    Dong Wang, Qian Cui, Yan Jie Yang, A.Qing Liu, Guan Zhang, Jian Chun Yu · 2022 · Biomedicine & Pharmacotherapy
  3. Activation of dendritic cells by toll-like receptors and C-type lectins.
    S. Diebold · 2009 · Handbook of Experimental Pharmacology
  4. Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses
    Jing Zeng, Timothy J. Harris, Michael K. Lim, Charles G. Drake, Phuoc Tho Tran · 2013 · BioMed Research International
  5. Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice
    Débora De Melo Gagliato, Javier Cortés, Giuseppe Curigliano, Sherene Loi, Carsten Denkert, José Manuel Pérez-García, Esther Holgado · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. In-situ tumor vaccination: Bringing the fight to the tumor
    Robert Hamilton Pierce, Jean S. Campbell, Sara Isabel Pai, Joshua Brody, Holbrook E K Kohrt · 2015 · Human Vaccines & Immunotherapeutics
  7. Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic
    Kenneth Oguejiofor, Henry Galletta, Simon J. Dovedi, Darren L. Roberts, Peter L. Stern, Catharine West · 2017 · Oncotarget
  8. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
    Wei Xie, Sabrina Forveille, Kristina Iribarren, Allan Sauvat, Laura Senovilla, Yan Wang, Juliette F Humeau, María Pérez-Lanzón, Heng Zhou, Juan Fernando Martínez-Leal et al. · 2019 · OncoImmunology
  9. Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation
    Carmine Rocca, Teresa Pasqua, Maria Carmela Cerra, Tommaso Angelone · 2020 · Antioxidants and Redox Signaling
  10. Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens
    Paula Jaime‐Sánchez, Iratxe Uranga-Murillo, Nacho Aguiló, Sofía C. Khouili, Maykel A. Arias, David Sancho, Julián Pardo · 2020 · Journal for ImmunoTherapy of Cancer
  11. Effects of Radiation on the Tumor Microenvironment
    Arta Monir Monjazeb, Kurt Alex Schalper, Franz Villarroel‐Espíndola, Anthony Tuan Nguyen, Stephen Lawrence Shiao, Kristina Hoot Young · 2020 · Seminars in Radiation Oncology
  12. Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway
    Julie Constanzo, Julien Faget, Chiara Ursino, Christophe Badie, Jean‐Pierre Pouget · 2021 · Frontiers in Immunology
  13. Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis
    Kei‐ichiro Arimoto, Sayuri Miyauchi, Ty D. Troutman, Yue Zhang, Mengdan Liu, Samuel A. Stoner, Amanda G Davis, Jun-Bao Fan, Yi-Jou Huang, Ming Yan et al. · 2023 · Nature Communications
  14. Distinct signalling mechanisms mediate neutrophil attraction to bacterial infection and tissue injury
    Qing Deng, Elizabeth A. Harvie, Anna Huttenlocher A · 2011 · Cellular Microbiology
  15. Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models
    Harm HogenEsch, Alexander Yu. Nikitin · 2012 · Journal of Controlled Release
  16. Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer
    Fu Gao, Cong Liu, Jiaming Guo, Weimin Sun, Linfeng Xian, Dongchen Bai, Hu Liu, Ying Cheng, Bailong Li, Jianguo Cui et al. · 2015 · Scientific Reports
  17. Targeting the interleukin-1 pathway in patients with hematological disorders
    Charlotte E. M. de Mooij, Mihai Gheorghe Netea, Walter J. F. M. van der Velden, Nicole M. A. Blijlevens · 2017 · Blood
  18. Macrophage efferocytosis in health and disease
    Shokufeh Razi, Javad Yaghmoorian Khojini, Fateme Kargarijam, Susan Panahi, Zahra Tahershamsi, Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat · 2023 · Cell Biochemistry and Function
  19. HMGB1 in the interplay between autophagy and apoptosis in cancer
    Ruochan Chen, Ju Zou, Xiao Yan Zhong, Jie Li, Rui Kang, Daolin Tang · 2023 · Cancer Letters
  20. Toll-like Receptor 4 Signaling Promotes Tumor Growth
    Che‐Hsin Lee, Chao‐Liang Wu, Ai‐Li Shiau · 2009 · Journal of Immunotherapy
  21. HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
    Clarissa Anni Wild, Sven Brandau, Ramin Lotfi, Stefan Mattheis, Xiang Gu, Stephan Lang, Christoph Bergmann · 2012 · Oral Oncology
  22. Tumor microenvironment and lymphocyte infiltration
    Gwendoline Rahir, Muriel Moser · 2012 · Cancer Immunology Immunotherapy
  23. Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with 188Re-lipid nanocapsules
    Claire Vanpouille‐Box, Franck Lacœuille, Camille Daviaud, Nicolas Lepareur, Laurent P. Lemaire, Jean-Jacques Lejeune, Jean‐Pierre Benoît, Philippe Meneï, Olivier Couturier, Emmanuel Garcion et al. · 2011 · Biomaterials
  24. Carbon monoxide–based therapy ameliorates acute pancreatitis via TLR4 inhibition
    Jing Xue, Aida Habtezion · 2013 · Journal of Clinical Investigation
  25. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
    George E. Theodoropoulos, Vasilios Saridakis, Theodoros Karantanos, Nikolaos V. Michalopoulos, Flora Zagouri, Panagiota Kontogianni, Maria Lymperi, Maria Gazouli, George Zografos · 2012 · The Breast
  26. Radiotherapy and immune checkpoints inhibitors for advanced melanoma
    Andrea Riccardo Filippi, Paolo Fava, Serena Badellino, Chiara Astrua, Umberto Ricardi, Pietro Quaglino · 2016 · Radiotherapy and Oncology
  27. Exosomes and the Future of Immunotherapy in Pancreatic Cancer
    Inês A. Batista, Sónia A. Melo · 2019 · International Journal of Molecular Sciences
  28. Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
    Jared M. Newton, Aurélie Hanoteau, Hsuan‐Chen Liu, Angelina Gaspero, Falguni Parikh, Robyn D. Gartrell, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj et al. · 2019 · Journal for ImmunoTherapy of Cancer
  29. Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease
    Edward Benjamin Thorp · 2010 · APOPTOSIS
  30. Carbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma
    Akinao Matsunaga, Yasuji Ueda, Shigeru Yamada, Yui Harada, Hideaki Shimada, Mamoru Hasegawa, Hirohiko Tsujii, Takenori Ochiai, Yoshikazu Yonemitsu · 2010 · Cancer
  31. DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
    Walter Gottlieb Land, Patrizia Agostinis, Stephan Gasser, Abhishek Dinkarnath Garg, Andreas Linkermann · 2016 · American Journal of Transplantation
  32. Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
    Maiko Niki, Aya Nakaya, Takayasu Kurata, Hiroshige Yoshioka, Toshihiko Kaneda, Kayoko Kibata, Makoto Ogata, Shosaku� Nomura · 2018 · Oncotarget
  33. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models
    Juliette F Humeau, Sarah Lévesque, Guido Kroemer, Jonathan G. Pol · 2018 · Methods in molecular biology
  34. Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma
    Yutaka Takahashi, Tomohiro Yasui, Kazumasa Minami, Keisuke Tamari, Kazuhiko Hayashi, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi, Kazuhiko Ogawa · 2019 · Oncotarget
  35. Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer
    Yuichi Ozawa, Yusuke Amano, Kei Kanata, Hasegwa Hirotsugu, Takashi Matsui, Takuya Kakutani, Takafumi Koyauchi, Masayuki Tanahashi, Hiroshi Niwa, Koshi Yokomura et al. · 2019 · Medical Oncology
  36. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
    Marion Tonneau, Arielle Elkrief, Dominique Pasquier, Thomas Paz del Socorro, Mathias Chamaillard, Houda Bahig, Bertrand Routy · 2020 · Radiotherapy and Oncology
  37. Radiotherapy: An immune response modifier for immuno-oncology
    Mara De Martino, Camille Daviaud, Claire Vanpouille‐Box · 2021 · Seminars in Immunology
  38. A model for cancer-suppressive inflammation
    Ole Audun Werner Haabeth, Bjarne Bogen, Alexandre Corthay · 2012 · OncoImmunology
  39. Tissue Damage–Associated “Danger Signals” Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer
    Ying He, Jikun Zha, Yamin Wang, Wenhua Liu, Xuanming Yang, Ping Yu · 2012 · Cancer Research
  40. Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
    Claudia Omarini, Giorgia Guaitoli, Stefania Pipitone, Luca I. Moscetti, Laura Cortesi, Stefano Cascinu, Federico Piacentini · 2018 · Cancer Management and Research
  41. In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
    Isabella Lurje, Wiebke Werner, Raphael U. Mohr, Christoph Roderburg, Frank Tacke, Linda Hammerich · 2021 · Frontiers in Immunology
  42. Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity
    Changping Zhou, Lu Ma, Han Xu, Yingqing Huo, Jincai Luo · 2022 · Cell Research
  43. Immunogenic Cell Death in Cancer Therapy
    Olga S. Troitskaya, Diana D. Novak, Vladimir Alexandrovich Richter, Olga A. Koval · 2022 · Acta Naturae
  44. Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer
    Megan Eileen Daly, Arta Monir Monjazeb, Karen L. Kelly · 2015 · Journal of Thoracic Oncology
  45. Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone
    Liliana Endo‐Munoz, Andrew Cumming, Scott M. M. Sommerville, Ian C. Dickinson, Nicholas Andrew Saunders · 2010 · British Journal of Cancer
  46. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?
    Mitchell R. Kamrava, Michael B. Bernstein, Kevin A. Camphausen, James W. Hodge · 2009 · Molecular BioSystems
  47. Molecular determinants of sterile inflammation
    Hajime Kono, Akiko Onda, Tamiko Yanagida · 2014 · Current Opinion in Immunology
  48. Association of Toll-Like Receptor 4 Polymorphisms with Diabetic Foot Ulcers and Application of Artificial Neural Network in DFU Risk Assessment in Type 2 Diabetes Patients
    Kanhaiya Singh, Vivek Kumar Singh, Neeraj Kumar Agrawal, Sanjeev Gupta, Kiran Singh · 2013 · BioMed Research International
  49. Danger signals: Chemotherapy enhancers?
    Thaiz Rivera Vargas, Lionel Apétoh · 2017 · Immunological Reviews
  50. The renaissance of anti‐neoplastic immunity from tumor cell demise
    Yuting Ma, Jonathan M. Pitt, Qingqing Li, Heng Yang · 2017 · Immunological Reviews
  51. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
    Mauricio S. Caetano, Ahmed I. A. Younes, Hampartsoum B. Barsoumian, Michael M. Quigley, Hari Menon, Chan Gao, Thomas E. Spires, Timothy P. Reilly, Alexandra P. Cadena, Taylor R. Cushman et al. · 2019 · Clinical Cancer Research
  52. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
    Somaiyeh Malekghasemi, Jafar Majidi, Amir Baghbanzadeh, Jalal Abdolalizadeh, Behzad Baradaran, Leili Aghebati Maleki · 2020 · Advanced Pharmaceutical Bulletin
  53. Oncolytic Viral Therapy Using Reovirus
    Chandini M. Thirukkumaran, Don G. Morris · 2015 · Methods in molecular biology
  54. Immune cells: plastic players along colorectal cancer progression
    Giuseppe Di Caro, Federica Marchesi, Luigi Laghi, Fabio Grizzi · 2013 · Journal of Cellular and Molecular Medicine
  55. Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
    Chiara Napoletano, Filippo Bellati, Rachele Landi, Simona Pauselli, Cláudia Marchetti, Valeria V. Visconti, Patrizio Sale, Marco Liberati, Aurelia Rughetti, Luigi Frati et al. · 2009 · Journal of Cellular and Molecular Medicine
  56. Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
    Chrystal Mary Paulos, Carl H. June · 2010 · Journal of Clinical Investigation
  57. Kill and Spread the Word: Stimulation of Antitumor Immune Responses in the Context of Radiotherapy
    Udo S. Gaipl, Gabriele Multhoff, Heike Scheithauer, Kirsten Lauber, S. Hehlgans, Benjamin Frey, Franz Rödel · 2014 · Immunotherapy
  58. Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments
    Adrien Procureur, Audrey Simonaggio, Jean‐Emmanuel Bibault, Stéphane Marie. Oudard, Yann Alexandre Vano · 2021 · Cancers
  59. Radiotherapy: Brightness and darkness in the era of immunotherapy
    Danyi Zhai, Dandan An, Chao Wan, Kunyu Yang · 2022 · Translational Oncology
  60. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example
    Qi Meng, Binbin Ding, Ping’an Ma, Jun Lin · 2023 · Small Methods
  61. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
    Guido Kroemer, Lorenzo Galluzzi, Laurence Zitvogel, Wolf H. Fridman · 2015 · OncoImmunology
  62. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer
    Robert E. Roses, Min Xu, Gary K. Koski, Brian J. Czerniecki · 2008 · Oncogene
  63. Manifestations and mechanisms of non-targeted effects of ionizing radiation
    Eric G. Wright · 2010 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  64. Role of Radiation Therapy as Immune Activator in the Era of Modern Immunotherapy for Metastatic Malignant Melanoma
    Derick K. Okwan-Duodu, Brian P. Pollack, David H. Lawson, Mohammad Khurram Khan · 2013 · American Journal of Clinical Oncology
  65. Unlocking the Combination: Potentiation of Radiation-Induced Antitumor Responses with Immunotherapy
    Max Miller Wattenberg, Ahmed Fahim, Mansoor M. Ahmed, James W. Hodge · 2014 · Radiation Research
  66. Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study
    Javier Martín‐Broto, Antonio Lopez Pousa, Ramón de las Peñas, Xavier García del Muro, Antonio M. Gutierrez, Javier Martínez‐Trufero, Josefina Cruz, Rosa Maria Alvarez, Ricardo Cubedo, Andrés Redondo et al. · 2016 · Journal of Clinical Oncology
  67. Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
    Shigeo Koido · 2016 · International Journal of Molecular Sciences
  68. Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro
    Haifang Wang, Fen Ning, Zongcai Liu, Long Wu, Zi-Qian Li, Yi-Fei Qi, Ge Zhang, Hongsheng Wang, Shaohui Cai, Jun Du · 2016 · Cancer Immunology Immunotherapy
  69. Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion—A New Role for the AXL Receptor Tyrosine Kinase
    Todd Anthony Aguilera, Amato J. Giaccia · 2017 · Clinical Cancer Research
  70. Life after death: targeting high mobility group box 1 in emergent cancer therapies.
    Zong Sheng Guo, Zuqiang Liu, David L. Bartlett, Daolin Tang, Michael T. Lotze · 2013 · Europe PMC (PubMed Central)
  71. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
    Yiannis Philippou, Hanna T. Sjoberg, Emma A. Murphy, Said Alyacoubi, Keaton Ian Jones, Alex Nicolas Gordon-Weeks, Su Myat Phyu, Eileen E. Parkes, William Gillies McKenna, Alastair D.G. Lamb et al. · 2020 · British Journal of Cancer
  72. Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles
    Michael Ioannis Koukourakis, Alexandra N. Giatromanolaki · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  73. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy
    Wen Deng, Haojie Shang, Yonghua Tong, Xiao Liu, Qiu Huang, Yu Ting He, Jian Wu, Xiaozhuo Ba, Zhiqiang Chen, Yuan Chen et al. · 2024 · Journal of Nanobiotechnology
  74. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
    Puja Sandbhor, Pranoti Palkar, Sakshi Bhat, Geofrey John, Jayant Sastri Goda · 2024 · Nanoscale
  75. Tumor Antigen Cross‐Presentation and the Dendritic Cell: Where it All Begins?
    Alison M. McDonnell, Bruce W.S. Robinson, Andrew J Currie · 2010 · Journal of Immunology Research
  76. New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
    Luis de la Cruz‐Merino, Antonio Barco-Sánchez, Fernando Henao, Esteban Nogales Fernández, Ana Vallejo Benítez, Javier Brugal Molina, Antonio Martínez-Peinado, Ana Grueso López, Manuel Ruíz Borrego, Manuel Codes Manuel de Villena et al. · 2013 · Clinical and Developmental Immunology
  77. Akt signaling pathway: a target for radiosensitizing human malignant glioma
    Emmanuel Chautard, Gaëlle Loubeau, Andréï Tchirkov, Jacques CHASSAGNE, Claudine Vermot‐Desroches, Laurent Morel, Pierre Verrelle · 2010 · Neuro-Oncology
  78. Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
    Melanie J. McCoy, Chris Hemmings, Timothy J. Miller, Stephanie J. Austin, Max Kishor Bulsara, Nikolajs Zeps, Anna K. Nowak, Richard Lake, Cameron F E Platell · 2015 · British Journal of Cancer
  79. High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation
    Sook Young Kim, Myoungsun Son, Sang Eun Lee, In Ho Park, Man Sup Kwak, Myeonggil Han, Hyun Sook Lee, Eun Sook Kim, Jae‐Young Kim, Jong Eun Lee et al. · 2018 · Frontiers in Immunology
  80. Harnessing dendritic cells in cancer
    Lionel Apétoh, Clara Locher, François Ghiringhelli, Guido Kroemer, Laurence Zitvogel · 2011 · Seminars in Immunology
  81. Combining immunotherapy and radiotherapy in lung cancer
    Neeraj Bhalla, Rachel C. Brooker, Michael Brada · 2018 · Journal of Thoracic Disease
  82. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
    Kunlin Wu, Huihao Zhang, Yajuan Fu, Youzhi Zhu, Lingjun Kong, Ling Chen, Feng Zhao, Liangfei Yu, Xiangjin Chen · 2018 · Molecular Medicine Reports
  83. The yin and yang of imaging tumor associated macrophages with PET and MRI
    Sudip Mukherjee, Dominik Sonanini, Andreas Maurer, Heike Elisabeth Daldrup-Link · 2019 · Theranostics
  84. Advances in engineering local drug delivery systems for cancer immunotherapy
    Peter Abdou, Zejun Wang, Qian Chen, Amanda Chan, Daojia R. Zhou, Vivienne Gunadhi, Zhen Gu · 2020 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  85. Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
    Thashini Moodley, Moganavelli Singh · 2021 · Pharmaceutics
  86. Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1α
    Noriho Iida, Yasunari Nakamoto, Tomohisa Baba, Hidetoshi Nakagawa, Eishiro Mizukoshi, Makoto Naito, Naofumi Mukaida, Shuichi Kaneko · 2010 · Cancer Research
  87. Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
    Heleen Dewitte, Rein Verbeke, Karine Breckpot, Stefaan C. De Smedt, Ine Lentacker · 2014 · Nano Today
  88. Intratumoral injection of interleukin‐2 augments the local and abscopal effects of radiotherapy in murine rectal cancer
    Koji Yasuda, Takako Nirei, Nelson Hirokazu Tsuno, Hirokazu Nagawa, Joji Kitayama · 2011 · Cancer Science
  89. Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity
    Maria Manuela Rosado, Myrtill Simkó, Mats‐Olof Mattsson, Claudio Pioli · 2018 · Frontiers in Public Health
  90. Impact of curcumin on toll‐like receptors
    Motahareh Boozari, Alexandra E. Butler, Amirhossein Sahebkar · 2019 · Journal of Cellular Physiology
  91. Enhancement of chemoradiation by co‐incorporation of gold nanoparticles and cisplatin into alginate hydrogel
    Mehri Mirrahimi, Maziar Khateri, Jaber Beik, Fatemeh S. Ghoreishi, Amin Shiralizadeh Dezfuli, Habib Ghaznavi, Ali Shakeri‐Zadeh · 2019 · Journal of Biomedical Materials Research Part B Applied Biomaterials
  92. Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
    Solmaz Ohadian Moghadam, Mohammad Reza Nowroozi · 2019 · Scandinavian Journal of Immunology
  93. Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors
    Xue Yang, Ying Yang, Jiayi Bian, Jiajia Wei, Zheng Wang, Zhanwei Zhou, Zhaoting Li, Minjie Sun · 2021 · Nano Today
  94. Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy
    Lijia Luo, Xiang Wang, Yu‐Pei Liao, Chong Hyun Chang, André E. Nel · 2022 · ACS Nano
  95. The abscopal effect in patients with cancer receiving immunotherapy
    Blessie Elizabeth Nelson, Jacob J. Adashek, Steven Hsesheng Lin, Vivek Subbiah · 2023 · Med
  96. Inflammation and neurodegeneration: the story ‘retolled’
    Janelle Drouin‐Ouellet, Francesca Cicchetti · 2012 · Trends in Pharmacological Sciences
  97. Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
    A.K.M. Ghulam Muhammad, Marianela Candolfi, Gwendalyn D. King, Kader Yagiz, David S. Foulad, Yohei Mineharu, Kurt M. Kroeger, Katherine A. Treuer, W. Stephen Nichols, Nicholas Sanderson et al. · 2009 · Clinical Cancer Research
  98. Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation
    Yuya Yoshimoto, Takahiro Oike, Noriyuki Okonogi, Yoshiyuki Suzuki, K. Ando, Hiroshi Sato, S.-e. Noda, M. Isono, Kosaku Mimura, Koji Kono et al. · 2015 · Journal of Radiation Research
  99. Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment
    Christopher Bastianpillai, Neophytos Petrides, Taimur Tariq Shah, Stephanie Guillaumier, Hashim Uddin Ahmed, Manit Arya · 2015 · Tumor Biology
  100. Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine?
    Bonnie Lee Hylander, Elizabeth A. Repasky · 2019 · International Journal of Hyperthermia